The emerging role of miR-208a in the heart

DNA and Cell Biology

Volumn 32, Issue 1, 2013, Pages 8-12

  Oliveira Carvalho, Vagner ^a   Carvalho, Vitor Oliveira ^a   Bocchi, Edimar Alcides ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 40; MICRORNA; MICRORNA 1; MICRORNA 133A; MICRORNA 133B; MICRORNA 208A; MICRORNA 208B; MICRORNA 499; MYOSIN HEAVY CHAIN; RNA BINDING PROTEIN; TRANSCRIPTION FACTOR GATA 4; TROPONIN T; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; CORONARY ARTERY DISEASE; DOWN REGULATION; GENE DELETION; HEART ARRHYTHMIA; HEART DEATH; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CONDUCTION SYSTEM; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBROSIS; HEART MUSCLE INJURY; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; UNSTABLE ANGINA PECTORIS; UPREGULATION;

ANIMALS; BASE SEQUENCE; BIOLOGICAL MARKERS; GENE EXPRESSION REGULATION; HEART DISEASES; HUMANS; MICRORNAS; MYOSIN HEAVY CHAINS; PROTEIN ISOFORMS; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 84873039388     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2012.1787     Document Type: Review

References (30)

1. Abbas, N.A., John, R.I., Webb, M.C., Kempson, M.E., Potter, A.N., Price, C.P., et al.(2005). Cardiac troponins andrenal function in nondialysis patients with chronic kidney disease. Clin Chem 51, 2059-2066
2. Babiarz, J.E., Ravon, M., Sridhar, S., Ravindran, P., Swanson, B., Bitter, H., et al.(2012). Determination of the human cardiomyocyte mRNA and miRNA differentiation network by finescale profiling. Stem Cells Dev 21, 1956-1965
3. Bell, M.L., Buvoli, M., and Leinwand, L.A. (2010). Uncoupling of expression of an intronic microRNA and its myosin host gene by exon skipping. Mol Cell Biol 30, 1937-1945
4. Boštjancic, E., Zidar, N., Š; tajer, D., and Glava-c, D. (2010 MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction. Cardiology 115, 163-169
5. Callis, T.E., Pandya, K., Seok, H.Y., Tang, R.H., Tatsuguchi, M., Huang, Z.P., et al.(2009). MicroRNA-208a is a regulator of cardiachypertrophy and conduction in mice. J Clin Invest 119, 2772-2786
6. Corsten, M.F., Dennert, R., Jochems, S., Kuznetsova, T., Devaux, Y., Hofstra, L., et al.(2010). Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet 3, 499-506
7. De Rosa, S., Fichtlscherer, S., Lehmann, R., Assmus, B., Dimmeler, S., and Zeiher, A.M. (2011). Transcoronary concentration gradients of circulating microRNAs. Circulation 124, 1936-1944
8. Devaux, Y., Vausort, M., Goretti, E., Nazarov, P.V., Azuaje, F., Gilson, G., et al.(2012). Use of circulating microRNAs to diagnose acute myocardial infarction. Clin Chem 58, 559-567
9. Fichtlscherer, S., De Rosa, S., Fox, H., Schwietz, T., Fischer, A., Liebetrau, C., Weber, M., Hamm, C.W., Röxe, T., Müller-Ardogan, M., Bonauer, A., Zeiher, A.M., and Dimmeler, S. (2010). Circulating microRNAs in patients with coronary artery disease. Circ Res 107, 677-684
10. Gidlöf, O., Andersson, P., van der Pals, J., Götberg, M., and Erlinge, D. (2011). Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples. Cardiology 118, 217-226
11. Grueter, C.E., van Rooij, E., Johnson, B.A., DeLeon, S.M., Sutherland, L.B., Qi, X., et al.(2012). A cardiac microRNA governs systemic energy homeostasis by regulation of MED13 Cell 149, 671-683
12. Gupta, M.P. (2007). Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure. J Mol Cell Cardiol 43, 388-403
13. Hunter, M.P., Ismail, N., Zhang, X., Aguda, B.D., Lee, E.J., Yu, L., et al.(2008). Detection of microRNA expression in human peripheral blood microvesicles. PLoS ONE 3, e3694
14. Jaffe, A.S., Ravkilde, J., Roberts, R., Naslund, U., Apple, F.S., Galvani, M., et al.(2000). It's time for a change to a troponin standard. Circulation 102, 1216-1220
15. Ji, X., Takahashi, R., Hiura, Y., Hirokawa, G., Fukushima, Y., and Iwai, N. (2009). Plasma miR-208 as a biomarker of myocardial injury. Clin Chem 55, 1944-1949
16. Kuwabara, Y., Ono, K., Horie, T., Nishi, H., Nagao, K., Kinoshita, M., Watanabe, S., Baba, O., Kojima, Y., Shizuta, S., Imai, M., Tamura, T., Kita, T., and Kimura, T. (2011). Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ Cardiovasc Genet 4, 446-454
17. Montgomery, R.L., Hullinger, T.G., Semus, H.M., Dickinson, B.A., Seto, A.G., Lynch, J.M., et al.(2011). Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure. Circulation 124, 1537-1547
18. Morkin, E. (2000). Control of cardiac myosin heavychain gene expression. Microsc Res Tech 50, 522-531
19. Oliveira-Carvalho, V., Carvalho, V.O., Silva, M.M., Guimaraës, G.V., and Bocchi, E.A. (2012). MicroRNAs: A new paradigm in the treatment and diagnosis of heart failure? Arq Bras Cardiol 98, 362-370
20. Prasanth, K.V., and Spector, D.L. (2007). Eukaryotic regulatory RNAs: An answer to the 'genome complexity' conundrum. Genes Dev 21, 11-42
21. Satoh, M., Minami, Y., Takahashi, Y., Tabuchi, T., and Nakamura, M. (2010). Expression of microRNA-208 is associated with adverse clinical outcomes in human dilated cardiomyopathy. J Card Fail 16, 404-410
22. Stelzer, J.E., Brickson, S.L., Locher, M.R., and Moss, R.L. (2007). Role of myosin heavy chain composition in the stretch activation response of rat myocardium. J Physiol 579, 161-173
23. van Rooij, E., and Olson, E.N. (2007). MicroRNAs: Powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest 117, 369-376
24. van Rooij, E., Quiat, D., Johnson, B.A., Sutherland, L.B., Qi, X., Richardson, J.A., et al.(2009). A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev Cell 17, 662-673
25. van Rooij, E., Sutherland, L.B., Qi, X., Richardson, J.A., Hill, J., and Olson, E.N. (2007). Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316, 575-579
26. Wang, G.K., Zhu, J.Q., Zhang, J.T., Li, Q., Li, Y., He, J., et al.(2010). Circulating microRNA: A novel potential biomarker for early diagnosis of acutemyocardial infarction in humans. Eur Heart J 31, 659-666
27. Weiss, A., and Leinwand, L.A. (1996). The mammalian myosin heavy chain gene family. Annu Rev Cell Dev Biol 12, 417-439
28. Widera, C., Gupta, S.K., Lorenzen, J.M., Bang, C., Bauersachs, J., Bethmann, K., Kempf, T., Wollert, K.C., and Thum, T. (2011 Diagnostic and prognostic impact of six circulating micro-RNAs in acute coronary syndrome. J Mol Cell Cardiol 51, 872-875
29. Wu, A.H., and Feng, Y.J. (1998). Biochemical differences between cTnT and cTnI and their significance for diagnosis of acute coronary syndromes. Eur Heart J 19, 25-29
30. Zhu, H., and Fan, G.C. (2011). Extracellular/circulating micro-RNAs and their potential role in cardiovascular disease. Am J Cardiovasc Dis 1, 138-149.